W. David Hager
About
In The Last Decade
W. David Hager
40 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 102
- Epidemiology 760
- Immunology 395
- Microbiology 342
- Public Health, Environmental and Occupational Health 244
- Infectious Diseases 216
Countries citing papers authored by W. David Hager
This map shows the geographic impact of W. David Hager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. David Hager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. David Hager more than expected).
Fields of papers citing papers by W. David Hager
This network shows the impact of papers produced by W. David Hager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. David Hager. The network helps show where W. David Hager may publish in the future.
Co-authorship network of co-authors of W. David Hager
This figure shows the co-authorship network connecting the top 25 collaborators of W. David Hager. A scholar is included among the top collaborators of W. David Hager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. David Hager. W. David Hager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 150 | |
| 2 | 14 | |
| 3 | 438 | |
| 4 | 25 | |
| 5 | 54 | |
| 6 | 2 | |
| 7 | Protocols for infectious diseases in obstetrics and gynecology | 6 |
| 8 | 46 | |
| 9 | 11 | |
| 10 | 10 | |
| 11 | 21 | |
| 12 | 4 | |
| 13 | 15 | |
| 14 | Comparative study of mezlocillin versus cefotaxime single-dose prophylaxis in patients undergoing vaginal hysterectomy | 4 |
| 15 | 7 | |
| 16 | Fetal tachycardia as an indicator of maternal and neonatal morbidity. | 8 |
| 17 | Treatment of serious obstetric and gynecologic infections with cefoxitin. | 7 |
| 18 | 91 | |
| 19 | 2 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.